Trials / Active Not Recruiting
Active Not RecruitingNCT06938906
Multimodal Therapy Impact on Pancreatic Cancer Survival
Survival Outcome Analysis on the Strategy Shift Integrating a Multimodal Therapy of Neoadjuvant Chemotherapy and Extended Pancreatectomy in Pancreatic Cancer: A Clinical Study From a Retrospective Cohort in a Single Institute
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 405 (actual)
- Sponsor
- National Cheng Kung University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this retrospective cohort study is to analyze change of treatment strategies affect the survival outcomes in patients of pancreatic cancer who received curative-intent treatment. The main question it aims to answer is: Hypothesis: Change of treatment strategies involving increased utility of neoadjuvant chemotherapy and aggressive surgical approaches of extended pancreatectomy improved the overall and progression free survival in the patients with pancreatic cancer. Participants received curative treatment for pancreatic cancer.
Detailed description
This study is to analyze the change of treatment strategies and shift of the paradigm over time in a single center. Researchers plan to see the impact of the evolvement to the survival outcomes in pancreatic cancer.
Conditions
Timeline
- Start date
- 2011-01-03
- Primary completion
- 2025-04-30
- Completion
- 2025-04-30
- First posted
- 2025-04-22
- Last updated
- 2025-04-24
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT06938906. Inclusion in this directory is not an endorsement.